Use of calcium channel antagonists in myocardial revascularization procedures

American Journal of Cardiology

Volumn 77, Issue 16, 1996, Pages 26D-31D

  Califf, Robert M ^a   Tardiff, Barbara E ^a   Pieper, Karen S ^a   Hillegass, William B ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT;

ATHERECTOMY; CORONARY ARTERY DILATATION; CORONARY ARTERY OBSTRUCTION; DRUG EFFICACY; HEART MUSCLE REVASCULARIZATION; HEART SURGERY; HUMAN; HYPERTENSION; PEROPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW;

EID: 0029893781     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(96)00305-0     Document Type: Article

References (28)

1. Ikeda Y, Kikuchi M, Toyama K, Watanabe K, Ando Y. Inhibition of human platelet functions by verapamil. Thromb Haemos 1981;45:2158-2161.
2. 2+-channel blockers inhibit the action of recombinant platelet-derived growth factor in vascular smooth muscle cells. Proc Natl Acad Sci USA 1989;86:2388-2392.
3. Parmley WW, Blumlein S, Sievers R. Modification of experimental atherosclerosis by calcium-channel blockers. Am J Cardiol 1985;55(suppl):165B-171B.
4. ++-antagonist lanthanum: possible role of calcium in atherogenesis. J Clin Invest 1980;65:967-981.
5. Forrester JS, Fishbein M, Helfant R, Fagin J. A paradigm for restenosis based on cell biology: clues for the development of new preventive therapies. J Am Coll Cardiol 1991;17:758-769.
6. Psaty BM, Heckbert SR, Koepsell TD, Siscovick DS, Raghunathan TE, Weiss NS, Rosendaal FR, Lemaitre RN, Smith NL, Wahl PW, Wagner EH, Furberg CD. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA 1995;274:620-625.
7. Furberg CD, Psaty BM. Calcium antagonists: antagonists or protagonists of mortality in elderly hypertensives? J Am Geriatr Soc 1995;43:1309-1310.
8. Messerli FH. Case-control study, meta-analysis, and bouillabaisse: putting the calcium antagonist scare into context. Ann Intern Med 1995;123:888-889.
9. Topol EJ, Leya F, Pinkerton CA, Whitlow PL, Hofling B, Simonton CA, Masden RR, Serruys PW, Leon MB, Williams DO, King SB III, Mark DB, Isner JM, Holmes DR Jr, Ellis SG, Lee KL, Keeler GP, Berdan LG, Hinohara T, Califf RM, for the CAVEAT Study Group. A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. N Engl J Med 1993;329:221-227.
10. Califf RM. Why are large-scale trials needed. Coron Artery Dis 1992;3:92-95.
11. Hillegass WB, Ohman EM, Leimberger JD, Califf RM. A meta-analysis of randomized trials of calcium antagonists to reduce restenosis after coronary angioplasty. Am J Cardiol 1995;73:835-839.
12. Corcos T, David PR, Val PG, Renkin J, Dangoisse V, Rapold HG, Bourassa MG. Failure of diltiazem to prevent restenosis after percutaneous transluminal coronary angioplasty. Am Heart J 1985;109:926-931.
13. Whitworth HB, Roubin GS, Hollman J, Meier B, Leimgruber PP, Douglas JS, King SB, Gruentiz AR. Effect of nifedipine on recurrent stenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1986;8:1271-1276.
14. Hoberg E, Schwarz F, Schomig A, Dieetz R, Schuler G, Katus HA, Rauch BL, Tillmanns H, Kubler W. Prevention of restenosis by verapamil. The Verapamil Angioplasty Study (VAS). Circulation 1990;82(suppl III):III-428.
15. O'Keefe JH, Giorgi LV, Hartzler GO, Good TH, Ligon RW, Webb DL, McCallister BD. Effects of diltiazem on complications and restenosis after coronary angioplasty. Am J Cardiol 1991;67:373-376.
16. Unverdorben M, Kunkel KB, Leucht M, Bachmann K. Reduction of restenosis after PTCA by diltiazem? Circulation 1992;86:1-53.
17. Held PH, Yusuf S. Calcium antagonists in the treatment of ischemic heart disease: myocardial infarction. Coron Artery Dis 1994;5:21-26.
18. Furberg CD, Psaty BM, Meyer JV. Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. Circulation 1995;92:1326-1331.
19. Hoberg E, Dietz R, Frees U, Katus HA, Rauch B, Schomig A, Schuler G, Schwarz F, Tillmanns H, Niebauer J. Verapamil treatment after coronary angioplasty in patients at high risk of recurrent stenosis. Br Heart J 1994;71:254-260.
20. The Epic Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994;330:956-961.
21. The Impact II Investigators. Effects of integrelin, a platelet glycoprotein IIb/IIIa inhibitor, in preventing ischemic complications of percutaneous coronary intervention. N Engl J Med (submitted).
22. Roberts AJ, Niarchos AP, Subramanian VA, Abel RM, Herman SD, Sealey JE, Case DB, White RP, Johnson GA, Laragh JH, Gay WA Jr. Systemic hypertension associated with coronary artery bypass surgery: predisposing factors, hemodynamic characteristics, humoral profile, and treatment J Thorac Cardiovasc Surg 1977;74:846-859.
23. Wallach R, Karp RB, Reves JG, Oparil S, Smith LR, James TN. Pathogenesis of paroxysmal hypertension developing during and after coronary bypass surgery: a study of hemodynamic and humoral factors. Am J Cordiol 1980;46:559-565.
24. Leslie J, Brister N, Levy JH, Yared JP, Marty A, Martin H, Hines R, Savino J, Cohen M. Treatment of postoperative hypertension after coronary artery bypass surgery: double-blind comparison of intravenous isradipine and sodium nitroprusside. Circulation 1994;90(part 2):II-256-II-261.
25. Seitelberger R, Zwolfer W, Huber S, Schwarzachere S, Binder TM, Peschl F, Spatt J, Holzinger C, Podesser B, Buxbaum P, Weber H, Wolner E. Nifedipine reduces the incidence of myocardial infarction and transient ischemia in patients undergoing coronary bypass grafting. Circulation 1991;83:460-468.
26. Leung JM, Browner WS. Nifedipine reduces the incidence of myocardial infarction and transient ischemia in patients undergoing coronary bypass grafting. [Letter.] Circulation 1992;85:2334-2335.
27. Wagenknecht LE, Furberg CD, Hammon JW, Legault C, Troost BT. Surgical bleeding: unexpected effect of a calcium antagonist. Br Med J 1995;310:776-777.
28. Andrews TC, Reimold SC, Berlin JA, Antman EM. Prevention of supraventricular arrhythmias after coronary artery bypass surgery. A metaanalysis of randomized control trials. Circulation 1991;84(suppl III):III-236-III-244.